A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal.
Current estimates of the prevalence of opioid withdrawal in newborns from the 2012 Better Outcomes Registry and Network Ontario reveal that more than 4 births per 1000 display recognizable symptoms of neonatal abstinence syndrome (NAS). With a growing consensus surrounding aspects of newborn opioid withdrawal care, clinicians might agree that all infants exposed to maternal opioids require supportive observation and care to ensure appropriate adaptation and growth in the newborn period and, likewise, that there exists a smaller percentage of newborns who require additional pharmacotherapy. However, due to the dearth of comparative studies of NAS tools, there remains a lack of evidence to support the use of a specific NAS method of scoring or treatment. Two types of NAS treatment protocols currently in use include a symptom-only versus weight-based protocols. Our Neonatal Intensive Care Unit (NICU) has used both models. A formal structured NAS tool and weight-based morphine delivery system began in our NICU in 1999. We audited all newborns with known exposure to maternal opioids in our NICU from the years 2000 to 2014. The Finnegan scoring tool was used throughout all years of the chart audit. Modifications made to the Finnegan scoring tool from the MOTHER study were adapted for use in our NICU at the same time as adopting the Johns Hopkins model of symptom-only based morphine delivery in 2006. The objective of this comparative study using a retrospective chart audit is to compare length of stay (LOS) and total accumulative morphine dose across these two morphine delivery protocols. Our audit revealed that there were a significantly higher proportion of newborns in the symptom-only model that received morphine and, perhaps accordingly, also had a significantly higher LOS compared to those in the weight-based model. Comparing only those infants who did receive morphine, the comparative total accumulative dose of morphine and LOS were not significantly different between the weight-based and symptom-only morphine delivery models.
Department of Paediatrics, St. Joseph's Health Centre, Toronto, Canada.
Brian
B
Chisamore
Department of Paediatrics, St. Joseph's Health Centre, Toronto, Canada.
Safaa
S
Labana
University Health Network, Toronto, Canada.
Sandra
S
Blitz
Department of Family and Community Medicine, St. Joseph's Health Centre, Toronto, Canada.
Alice
A
Ordean
methadone; neonatal abstinence syndrome; opioid withdrawal
Curr Opin Pediatr. 2012 Apr;24(2):252-8
22227786
Pediatrics. 2007 Sep;120(3):e734-8
17766513
Addiction. 2010 Dec;105(12):2071-84
20840198
Can Fam Physician. 2011 Nov;57(11):e430-5
22084472
Arch Dis Child Fetal Neonatal Ed. 2009 Jul;94(4):F249-52
19174414
Addict Dis. 1975;2(1-2):113-21
1163356
N Engl J Med. 2010 Dec 9;363(24):2320-31
21142534
J Perinatol. 2012 Jun;32(6):425-30
21852772
Am J Dis Child. 1974 Jan;127(1):58-61
4809795
J Perinatol. 2011 Nov;31(11):692-701
21869765
J Popul Ther Clin Pharmacol. 2012;19(3):e488-506
23241498
Pediatrics. 2014 Aug;134(2):e527-34
25070317
N Engl J Med. 2015 May 28;372(22):2118-26
25913111
BMJ. 2008 May 24;336(7654):1170-3
18497416
Prev Med. 2015 Nov;80:12-7
26232620
J Psychoactive Drugs. 1991 Apr-Jun;23(2):191-201
1765892
J Perinatol. 2006 Jan 1;26(1):15-7
16355103
JAMA. 2012 May 9;307(18):1974-5
22546607
Pediatrics. 2012 Feb;129(2):e540-60
22291123